<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30552635</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Recent Progress on Functional Genomics Research of Enterovirus 71.</ArticleTitle><Pagination><StartPage>9</StartPage><EndPage>21</EndPage><MedlinePgn>9-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12250-018-0071-9</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is one of the main pathogens that causes hand-foot-and-mouth disease (HFMD). HFMD caused by EV71 infection is mostly self-limited; however, some infections can cause severe neurological diseases, such as aseptic meningitis, brain stem encephalitis, and even death. There are still no effective clinical drugs used for the prevention and treatment of HFMD. Studying EV71 protein function is essential for elucidating the EV71 replication process and developing anti-EV71 drugs and vaccines. In this review, we summarized the recent progress in the studies of EV71 non-coding regions (5' UTR and 3' UTR) and all structural and nonstructural proteins, especially the key motifs involving in viral infection, replication, and immune regulation. This review will promote our understanding of EV71 virus replication and pathogenesis, and will facilitate the development of novel drugs or vaccines to treat EV71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiqiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuhuan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3725-3258</Identifier><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. yuhuanlibj@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. yuhuanlibj@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020413">3' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020121">5' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022661">RNA, Untranslated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020413" MajorTopicYN="N">3' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020121" MajorTopicYN="N">5' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022661" MajorTopicYN="N">RNA, Untranslated</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71 (EV71)</Keyword><Keyword MajorTopicYN="N">Functional genomics</Keyword><Keyword MajorTopicYN="N">Nonstructural protein</Keyword><Keyword MajorTopicYN="N">Structural protein</Keyword><Keyword MajorTopicYN="N">Viral protein function</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest. The authors declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30552635</ArticleId><ArticleId IdType="pmc">PMC6420560</ArticleId><ArticleId IdType="doi">10.1007/s12250-018-0071-9</ArticleId><ArticleId IdType="pii">10.1007/s12250-018-0071-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agirre A, Barco A, Carrasco L, Nieva JL. Viroporin-mediated membrane permeabilization. Pore formation by nonstructural poliovirus 2B protein. Biol Chem. 2002;277:40434&#x2013;40441.</Citation><ArticleIdList><ArticleId IdType="pubmed">12183456</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedard KM, Semler BL. Regulation of picornavirus gene expression. Microbes Infect. 2004;6:702&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">15158778</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Moncla LH, Ronderos MD, Friedrich TC, Osorio JE. A single mutation in the VP1 of enterovirus 71 is responsible for increased virulence and neurotropism in adult interferon-deficient mice. J Virol. 2016;90:8592&#x2013;8604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5021399</ArticleId><ArticleId IdType="pubmed">27440896</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa MJ, Perera D, Brown BA, Cheon D, Chan HM, Chan KP, Cho H, McMinn P. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis. 2003;9:461&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957976</ArticleId><ArticleId IdType="pubmed">12702227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CK, Wu SR, Chen YC, Lee KJ, Chung NH, Lu YJ, Yu SL, Liu CC, Chow YH. Mutations in VP1 and 5&#x2032;-UTR affect enterovirus 71 virulence. Sci Rep. 2018;8:6688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5923339</ArticleId><ArticleId IdType="pubmed">29703921</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen XM, Zhang Q, Li JH, Cao W, Zhang JX, Zhang L, Zhang WL, Shao ZJ, Yan YP. Analysis of recombination and natural selection in human enterovirus 71. Virology. 2010;398:251&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">20060995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SC, Chang LY, Wang YW, Chen YC, Weng KF, Shih SR, Shih HM. Sumoylation promoted enterovirus 71 3C degradation correlates with a reduction in viralreplication and cell apoptosis. J Biol Chem. 2011;286:31373&#x2013;31384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173077</ArticleId><ArticleId IdType="pubmed">21784861</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Song Z, Qi Y, Feng XF, Xu NQ, Sun YY, Wu X, Yao X, Mao QY, Li XL, Dong WJ, Wan XB, Huang N, Shen XL, Liang ZL, Li WH. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 proteininteracts with variable region on scavenge receptor B 2. J Biol Chem. 2012;287:6406&#x2013;6420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DY, Feng CH, Tian XY, Zheng N, Wu ZW. Promyelocytic leukemia restricts enterovirus 71 replication by inhibiting autophagy. Front Immunol. 2018;9:1268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5996053</ArticleId><ArticleId IdType="pubmed">29922292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#x2019;ng WC, Stanbridge EJ, Wong KT, Ong KC, Yusoff K, Shafee N. Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters. Virol J. 2012;9:155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3462122</ArticleId><ArticleId IdType="pubmed">22877087</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe SS, Dodd DA. Kirkegaard K. Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology. 2005;337:18&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">15914217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong HL, Ning D, Tian HC, Yang Y, Zhang W, Zhang H, Zhang WL, Song L, Tien P. Enterovirus 71 VP1 Activates Calmodulin-Dependent Protein Kinase II and Results in the Rearrangement of Vimentin in Human Astrocyte Cells. PLoS ONE. 2013;8:e73900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3779202</ArticleId><ArticleId IdType="pubmed">24073199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong HL, Du N, Yang Y, Song L, Zhang WL, Tien P. Enterovirus 71 2B induces cell apoptosis by directly inducing the conformational activation of the proapoptotic protein Bax. J Virol. 2016;90:9862&#x2013;9877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5068536</ArticleId><ArticleId IdType="pubmed">27558414</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S, Wang J, Fan TT, Qin B, Guo L, Lei XB, Wang JW, Wang MT, Jin Q. Crystal structure of human enterovirus 71 3C protease. J Mol Biol. 2011;408:449&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="pubmed">21396941</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jong AS, Wessels E, Dijkman HBPM, Galama JM, Melchers WJ, Willems PH, van Kuppeveld FJ. Determinants for membrane association and permeabilization of the coxsackie virus 2B protein and the identification of the Golgi complex as the target organelle. J Biol Chem. 2003;278:1012&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pubmed">12244057</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng JX, Nie XJ, Lei YF, Ma CF, Xu DL, Li B, Xu ZK, Zhang GC. The highly conserved 5&#x2019; untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2&#x2019;-modified siRNAs. J Biomed Sci. 2012;19:73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3438048</ArticleId><ArticleId IdType="pubmed">22889374</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N, Cong HL, Tian HC, Zhang H, Zhang WL, Song L, Tien P. Cell surface vimentin is an attachment receptor for enterovirus 71. J Virol. 2014;88:5816&#x2013;5833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Du HW, Yin PQ, Yang XJ, Zhang LL, Jin Q, Zhu GF. Enterovirus 71 2C protein inhibits NF-&#x3ba;B activation by binding to RelA(p65) Sci Rep. 2015;5:14302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4585786</ArticleId><ArticleId IdType="pubmed">26394554</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng CH, Fu YX, Chen DY, Wang HR, Su AR, Zhang L, Chang L, Zheng N, Wu ZW. miR-127-5p negatively regulates enterovirus 71 replication by directly targeting SCARB2. FEBS Open Bio. 2017;7:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5458453</ArticleId><ArticleId IdType="pubmed">28593131</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Miragall O, Lopez de Quinto S, Martinez-Salas E. Relevance of RNA structure for the activity of picornavirus IRES elements. Virus Res. 2009;139:172&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">18692097</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, Poh CL. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 2007;125:61&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">17222936</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DG, Macary PA, Alonso S, Poh CL. Identification of human CD4 T-cell epitopes on the P1 capsid protein of enterovirus 71. Viral Immunol. 2008;21:215&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">18419256</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Sudaka Y, Takashino A, Kobayashi K, Kataoka C, Suzuki T, Iwata-Yoshikawa N, Kotani O, Ami Y, Shimizu H, Nagata N, Mizuta K, Matsuzaki Y, Koike S. VP1 amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection. J Virol. 2018;pii:JVI.00682-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita K, Krishnakumar SS, Franco D, Paul AV, London E, Wimmer E. Membrane topography of the hydrophobic anchor sequence of poliovirus 3A and 3AB proteins and the functional effect of 3A/3AB membrane association upon RNA replication. Biochemistry. 2007;46:5185&#x2013;5199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2519882</ArticleId><ArticleId IdType="pubmed">17417822</ArticleId></ArticleIdList></Reference><Reference><Citation>Giachetti C, Hwang SS, Semler BL. Cis-acting lesions targeted to the hydrophobic domain of a Poliovirus membrane-protein involved in RNA replication. J Virol. 1992;66:6045&#x2013;6057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC241482</ArticleId><ArticleId IdType="pubmed">1326655</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan HX, Tian J, Qin B, Wojdyla JA, Wang B, Zhao ZD, Wang MT, Cui S. Crystal structure of 2C helicase from enterovirus 71. Sci Adv. 2017;3:e1602573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409451</ArticleId><ArticleId IdType="pubmed">28508043</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Wang LY, Cui J, Song Y, Luo Z, Chen JB, Xiong Y, Zhang Q, Liu F, Ho WZ, Liu YL, Wu KL, Wu JG. SIRT1 inhibits EV71 genome replication and RNA translation by interfering with the viral polymerase and 5&#x2032;UTR RNA. J Cell Sci. 2016;129:4534&#x2013;4547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5201017</ArticleId><ArticleId IdType="pubmed">27875274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellen CU, Lee CK, Wimmer E. Determinants of substrate recognition by poliovirus 2A proteinase. J Virol. 1992;66:3330&#x2013;3338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC241111</ArticleId><ArticleId IdType="pubmed">1316450</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold J, Andino R. Poliovirus RNA replication requires genome circularization through a protein-protein bridge. Mol Cell. 2001;7:581&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129834</ArticleId><ArticleId IdType="pubmed">11463383</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero LJ, Lee CS, Hurrelbrink RJ, Chua BH, Chua KB, McMinn PC. Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997-2000. Arch Virol. 2003;148:1369&#x2013;1385.</Citation><ArticleIdList><ArticleId IdType="pubmed">12827466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu YY, Liu YN, Wang W, Kao FJ, Kung SH. In vivo dynamics of enterovirus protease revealed by fluorescence resonance emissiontransfer (FRET) based on a novel FRET pair. Biochem Biophys Res Commun. 2007;353:939&#x2013;945.</Citation><ArticleIdList><ArticleId IdType="pubmed">17207462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YC, Hsu JT, Huang JH, Ho MS, Ho YC. Formation of enteroviruslike particle aggregates by recombinant baculoviruses coexpressing P1 and 3CD in insect cells. Biotechnol Lett. 2003;25:919&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pubmed">12889824</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SC, Hsu YW, Wang HC, Huang SW, Kiang D, Tsai HP, Wang SM, Liu CC, Lin KH, Su IJ, Wang JR. Appearance of intratypic recombination of enterovirus 71 in Taiwan from 2002 to 2005. Virus Res. 2008;131:250&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">18036697</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PN, Lin JY, Locker N, Kung YA, Hung CT, Lin JY, Huang HI, Li ML, Shih SR. Far Upstream Element Binding Protein 1 Binds the Internal Ribosomal Entry Site of Enterovirus 71 and Enhances Viral Translation and Viral Growth. Nucleic Acids Res. 2011;19:9633&#x2013;9648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3239202</ArticleId><ArticleId IdType="pubmed">21880596</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Wang YF, Yu CK, Su IJ, Wang JR. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology. 2012;422:132&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung CT, Kung YA, Li ML, Brewer G, Lee KM, Liu ST, Shih SR. Additive Promotion of Viral Internal Ribosome Entry Site-Mediated Translation by Far Upstream Element-Binding Protein 1 and an Enterovirus 71-Induced Cleavage Product. PLoS Pathog. 2016;12:e1005959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079569</ArticleId><ArticleId IdType="pubmed">27780225</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang HB, Weng LY, Zhang N, Arita M, Li RQ, Chen LJ, Toyoda T. Biochemical characterization of enterovirus 71 3D RNA polymerase. Biochim Biophys Acta. 2011;1809:211&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">21220056</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KL, Sarnow P. Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus. J Virol. 1991;65:4341&#x2013;4349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC248873</ArticleId><ArticleId IdType="pubmed">1649334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener TK, Jia Q, Lim XF, He F, Meng T, Chow VT, Kwang J. Characterization and specificity of the linear epitope of the Enterovirus 71 VP2 protein. Virol J. 2012;9:55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3307493</ArticleId><ArticleId IdType="pubmed">22361222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener TK, Jia Q, Meng T, Chow VT, Kwang J. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highlyconserved &#x201c;knob&#x201d; region of VP3 protein. PLoS Negl Trop Dis. 2014;8:e2895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4038473</ArticleId><ArticleId IdType="pubmed">24875055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Sudaka Y, Takashino A, Imura A, Fujii K, Koike S. Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice. J Virol. 2018;pii:JVI.00681-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kung SH, Hsu YY, Liu WT. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol. 2002;83:1367&#x2013;1376.</Citation><ArticleIdList><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Li ML, Hsu TA, Chang SC, Lee JC, Chen CC, Stollar V, Shih SR. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293:386&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CJ, Shie JJ, Fang JM, Yen GR, Hsu JT, Liu HG, Tseng SN, Chang SC, Lee CY, Shih SR, Liang PH. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem. 2008;16:7388&#x2013;7398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125518</ArticleId><ArticleId IdType="pubmed">18583140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kao LT, Lin SJ, Wang RY, Shih SR. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS ONE. 2013;8:e63431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal SK, Kumar P, Yeo WM, Kar-Roy A, Chow VT. The VP1 protein of human enterovirus 71 self-associates via an interaction domain spanning amino acids 66-297. J Med Virol. 2006;78:582&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">16555287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JC, Shih SR, Chang TY, Tseng HY, Shih YF, Yen KJ, Chen WC, Shie JJ, Fang JM, Liang PH, Chao YS, Hsu JT. A mammalian cellbased reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71. Anal Biochem. 2008;375:115&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">18190777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PH, Liu CM, Ho TS, Tsai YC, Lin CC, Wang YF, Chen YL, Yu CK, Wang SM, Liu CC, Shiau AL, Lei HY, Chang CP. Enterovirus 71 Virion- Associated Galectin-1 Facilitates Viral Replication and Stability. PLoS ONE. 2015;10:e0116278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338065</ArticleId><ArticleId IdType="pubmed">25706563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei XB, Liu XL, Ma YJ, Sun ZM, Yang YW, Jin Q, He B, Wang JW. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type i interferon responses. J Virol. 2010;84:8051&#x2013;8061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei XB, Sun ZM, Liu XL, Jin Q, He B, Wang JW. Cleavage of the adaptor protein trif by enterovirus 71 3C inhibits antiviral responses mediated by toll-like receptor 3. J Virol. 2011;85:8811&#x2013;8818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei XB, Xiao X, Xue QH, Jin Q, He B, Wang JW. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol. 2013;87:1690&#x2013;1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei XB, Han N, Xiao X, Jin Q, He B, Wang JW. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB 1/TAB 2/TAB 3complex. J Virol. 2014;88:9830&#x2013;9841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136319</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei XB, Xiao X, Zhang ZZ, Ma YJ, Qi JL, Wu C, Xiao Y, Zhou Z, He B, Wang JW. The Golgi protein ACBD3 facilitates Enterovirus 71 replication by interacting with 3A. Sci Rep. 2017;7:44592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5356004</ArticleId><ArticleId IdType="pubmed">28303920</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, Chen CC, Stollar V, Shih SR. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293:386&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Zheng ZH, Liu Y, Zhang ZF, Liu QS, Meng J, Ke XL, Hu QX, Wang HZ. 2C proteins of enteroviruses suppress IKK&#x3b1; phosphorylation by recruiting protein phosphatase 1. J Virol. 2016;90:5141&#x2013;5151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4859720</ArticleId><ArticleId IdType="pubmed">26962213</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Yao YF, Chen Y, Xu X, Lin YQ, Yang ZL, Qiao WT, Tan J (2017) Enterovirus 71 3C promotes apoptosis through cleavage of PinX1, a telomere binding protein. J Virol 91:pii:e02016-16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5215332</ArticleId><ArticleId IdType="pubmed">27847364</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XH, Huang Y, Sun MH, Ji H, Dou H, Hu J, Yan YF, Wang X, Chen LY. Honeysuckle-encoded microRNA2911 inhibits Enterovirus 71 replication via targeting VP1 gene. Antiviral Res. 2018;152:117&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">29458129</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZL, Ning SS, Su X, Liu X, Wang H, Liu Y, Zheng WW, Zheng BS, Yu XF, Zhang WY (2018b) Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G. Nucleic Acids Res. 10.1093/nar/gky840</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6265463</ArticleId><ArticleId IdType="pubmed">30247716</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Huang PN, Chien KY, Horng JT, Shih SR. Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5&#x2032; untranslated region and participates in virus replication. J Gen Virol. 2008;89:2540&#x2013;2549.</Citation><ArticleIdList><ArticleId IdType="pubmed">18796723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Chen TC, Weng KF, Chang SC, Chen LL, Shih SR. Viral and host proteins involved in picornavirus life cycle. J Biomed Sci. 2009;16:103&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785775</ArticleId><ArticleId IdType="pubmed">19925687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Shih SR. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 2009;37:47&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615614</ArticleId><ArticleId IdType="pubmed">19010963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Shih SR, Pan M, Li C, Lue CF, Stollar V, Li ML. hnRNP A1 interacts with the 5&#x2032; untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J Virol. 2009;83:6106&#x2013;6114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2687368</ArticleId><ArticleId IdType="pubmed">19339352</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Brewer G. mRNA decay factor AUF1 binds the internal ribosomal entry site of enterovirus 71 and inhibits virus replication. PLoS ONE. 2014;9:e103827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117571</ArticleId><ArticleId IdType="pubmed">25077793</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Brewer G, Li ML. HuR and Ago2 Bind the Internal Ribosome Entry Site of Enterovirus 71 and Promote Virus Translation and Replication. PLoS ONE. 2015;10:e0140291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4599798</ArticleId><ArticleId IdType="pubmed">26451954</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Franco D, Paul AV, Wimmer E. Tyrosine 3 of poliovirus terminal peptide VPg(3B) has an essential function in RNA replication in the context of its precursor protein, 3AB. J Virol. 2007;81:5669&#x2013;5684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1900252</ArticleId><ArticleId IdType="pubmed">17360746</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol. 2012;86:3767&#x2013;3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Dong XC, Li YX, Zhang Q, Kim C, Song Y, Kang L, Liu YL, Wu KL, Wu JG. PolyC-Binding Protein 1 Interacts with 5,-Untranslated Region of Enterovirus 71 RNA in Membrane- Associated Complex to Facilitate Viral Replication. PLoS ONE. 2014;9:e87491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906175</ArticleId><ArticleId IdType="pubmed">24489926</ArticleId></ArticleIdList></Reference><Reference><Citation>Madan V, Sanchez-Martinez S, Vedovato N, Rispoli G, Carrasco L, Nieva JL. Plasma membrane-porating domain in poliovirus 2B protein. A short peptide mimics viroporin activity. J Mol Biol. 2007;374:951&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pubmed">17963782</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley SJ, Curtis PS, Pain VM. eIF4G: translation&#x2019;s mystery factor begins to yield its secrets. RNA. 1997;3:1085&#x2013;1104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369552</ArticleId><ArticleId IdType="pubmed">9326485</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Lee H, Hafenstein S, Kataoka C, Wakita T, Bergelson JM, Shimizu H. Enterovirus 71 Binding to PSGL-1 on Leukocytes: vP1-145 Acts as a Molecular Switch to Control Receptor Interaction. PLoS Pathog. 2013;9:e1003511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Yin J, Mugavero J, Rieder E, Liu Y, Wimmer E. A &#x201c;slide-back&#x201d; mechanism for the initiation of protein-primed RNA synthesis by the RNA olymerase of poliovirus. J Biol Chem. 2003;278:43951&#x2013;43960.</Citation><ArticleIdList><ArticleId IdType="pubmed">12937178</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J. Enterovirus 71 infection: a new threat to global health. Lancet Neurol. 2008;7:868&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128195</ArticleId><ArticleId IdType="pubmed">18848307</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y, Xu Y, Zhang Y, Zhou H, Deng YQ, Li XF, Miao M, Zhang Q, Zhong B, Hu Y, Zhang FC, Wu L, Qin CF, Zhou X. Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals. Immunity. 2017;46:992&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pubmed">28636969</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowlands DJ, Tuthill TJ, Groppelli E, Rowlands DJ. Picornaviruses. Curr Top Microbiol Immunol. 2010;343:43&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3018333</ArticleId><ArticleId IdType="pubmed">20397067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Raychaudhuri S, Dasgupta A. Nuclear entry of poliovirus protease-polymerase precursor 3CD: implications for host cell transcription shut-off. Virology. 2004;320:195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">15016543</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Chiang C, Chen TC, Wu CN, Hsu JT, Lee JC, Hwang MJ, Li ML, Chen GW, Ho MS. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J Biomed Sci. 2004;11:239&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">14966374</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestri LS, Parilla JM, Morasco BJ, Ogram SA, Flanegan JB. Relationship between poliovirus negative-strand RNA synthesis and the length of the 3&#x2032; poly(A) tail. Virology. 2006;345:509&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">16297425</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim AC, Luhur A, Tan TM, Chow VT, Poh CL. RNA interference against enterovirus 71 infection. Virology. 2005;341:72&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">16083932</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan S, Tan X, Sun X, Lu G, Chen CC, Yan J, Liu J, Xu W, Gao GF. VP2 Dominated CD4&#x2009;+&#x2009;T Cell Responses against Enterovirus 71 and Cross-Reactivity against Coxsackievirus A16 and Polioviruses in a Healthy Population. J Immunol. 2013;191:1637&#x2013;1647.</Citation><ArticleIdList><ArticleId IdType="pubmed">23863902</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan YW, Hong WJ, Chu JJ. Inhibition of enterovirus VP4 myristoylation is a potential antiviral strategy for hand, foot and mouth disease. Antiviral Res. 2016;133:191&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">27520386</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Sam IC, Lee VS, Wong HV, Chan YF. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology. 2017;501:79&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang WF, Yang SY, Wu BW, Jheng JR, Chen YL, Shih CH, Lin KH, Lai HC, Tang P, Horng JT. Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J Biol Chem. 2007;282:5888&#x2013;5898.</Citation><ArticleIdList><ArticleId IdType="pubmed">17182608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang ZF, Xia HJ, Wang PP, Yang J, Zhao TY, Zhang Q, Hu YY, Zhou X. The identification and characterization of nucleicacid chaperone activity of human enterovirus 71 nonstructural protein 3AB. Virology. 2014;464&#x2013;465:353&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112070</ArticleId><ArticleId IdType="pubmed">25113906</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoh HL, Mohammad SS, Britton PN, Kandula T, Lorentzos MS, Booy R, Jones A, Rawlinson W, Ramachandran V, Rodriguez ML, Andrews PI, Dale RC, Farrar MA, Sampaio H. Clinical Characteristics and Functional Motor Outcomes of Enterovirus 71 Neurological Diseasein Children. JAMA Neurol. 2016;73:300&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">26785318</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd S, Towner JS, Brown DM, Semler BL. Replicationcompetent picornaviruses with complete genomic RNA 3&#x2032;noncoding region deletions. J Virol. 1997;71:8868&#x2013;8874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192356</ArticleId><ArticleId IdType="pubmed">9343250</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka ED, Sobo K, Stoppini L, Cagno V, Abdul F, Piuz I, Meylan P, Huang S, Constant S, Tapparel C. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfatebinding ability and modulates ex vivo tropism. PLoS Pathog. 2018;14:e1007190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventoso I, Carrasco L. A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects. J Virol. 2003;69:6280&#x2013;6288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189526</ArticleId><ArticleId IdType="pubmed">7666528</ArticleId></ArticleIdList></Reference><Reference><Citation>Victorio CB, Xu Y, Ng Q, Meng T, Chow VT, Chua KB. Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain) Emerging Microbes and Infections. 2016;5:e60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4932649</ArticleId><ArticleId IdType="pubmed">27329847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JR, Kung YH, Huang SW, Kiang D, Ho MS, Liu CC, Yu CK, Su IJ, Wang JR. Introduction of a strong temperature-sensitive phenotype into enterovirus 71 by altering an amino acid of virus 3D polymerase. Virology. 2010;396:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19906393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Wu Z, Jin Q. COPI Is Required for Enterovirus 71 Replication. PLoS ONE. 2012;7:e38035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3360637</ArticleId><ArticleId IdType="pubmed">22662263</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XM, Zhu CF, Bao WG, Zhao K, Niu JQ, Yu XF, Zhang WY. Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS ONE. 2012;7:e32405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315555</ArticleId><ArticleId IdType="pubmed">22479324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi XY, Lei XB, Zhang XY, Cui S, Wang JW, Jin Q, Zhao ZD. Enterovirus 71 Protease 2Apro Targets MAVS to Inhibit Anti-Viral Type I Interferon Responses. PLoS Pathog. 2013;9:e1003231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HB, Lei XB, Xiao X, Yang CF, Lu WL, Huang Z, Leng QB, Jin Q, He B, Meng GX, Wang JW. Reciprocal regulation between enterovirus 71 and the NLRP3 inflammasome. Cell Rep. 2015;12:42&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">26119741</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LC, Chen SO, Chang SP, Lee YP, Yu CK, Chen CL, Tseng PC, Hsieh CY, Chen SH, Lin CF. Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of IFN-&#x3b3; via Signaling Attenuation. J Virol. 2015;89:7028&#x2013;7037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4473548</ArticleId><ArticleId IdType="pubmed">25926657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XH, Wang HR, Li YX, Jin Y, Chu Y, Su AR, Wu ZW. TIA-1 and TIAR interact with 5&#x2032;UTR of enterovirus 71 genome and facilitate viral replication. Biochem Biophys Res Commun. 2015;466:254&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">26363455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HR, Chang L, Wang XH, Su AR, Feng CH, Fu YX, Chen DY, Zheng N, Wu ZW. MOV10 interacts with Enterovirus 71 genomic 5&#x2032;UTR and modulates viral replication. Biochem Biophys Res Commun. 2016;479:571&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">27666477</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HQ, Li K, Ma LL, Wu S, Hu J, Jiang JD, Li YH. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy. Virol J. 2017;14:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5234143</ArticleId><ArticleId IdType="pubmed">28081706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Wang B, Huang H, Zhang CY, Zhu YM, Pei B, Cheng CF, Sun L, Wang JW, Jin Q, Zhao ZD. Enterovirus 71 protease 2Apro and 3Cpro differentially inhibit the cellular endoplasmic reticulum-associated degradation (ERAD) pathway via distinct mechanisms, and enterovirus 71 hijacks ERAD component p97 to promote its replication. PLoS Pathog. 2017;13:e1006674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650186</ArticleId><ArticleId IdType="pubmed">28985237</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WB, Xiao F, Wan P, Pan P, Zhang YC, Liu F, Wu KL, Liu YL, Wu JG. EV71 3D protein binds with NLRP3 and enhances the assembly of inflammasome complex. PLoS Pathog. 2017;13:e1006123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5245909</ArticleId><ArticleId IdType="pubmed">28060938</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen BP, Dai HJ, Yang YH, Zhuang Y, Sheng R. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology. 2013;56:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">23594713</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng TY, Chen LC, Shyu HW, Chen SH, Wang JR, Yu CK, Lei HY, Yeh TM. Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antivir Res. 2005;67:31&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">15916817</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Li ML, Hung CT, Shih SR. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009;5:e1000593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Chen LL, Huang PN, Shih SR. Neural pathogenesis of enterovirus 71 infection. Microbes and infection/Institut Pasteur. 2010;12:505&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Regional Office for the Western Pacific (2018) Hand, foot and mouth disease situation update 2018. http://iris.wpro.who.int/handle/10665.1/14191</Citation></Reference><Reference><Citation>Wu KX, Ng MM, Chu JJ. Developments towards antiviral therapies against enterovirus 71. Drug Discov Today. 2010;15:1041&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108380</ArticleId><ArticleId IdType="pubmed">20974282</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Lou ZY, Miao Y, Yu Y, Dong H, Peng W, Bartlam M, Li XM, Rao ZH. Structures of EV71 RNA dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-andmouth disease pandemic in China. Protein Cell. 2010;1:491&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4875138</ArticleId><ArticleId IdType="pubmed">21203964</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia HJ, Wang PP, Wang GC, Yang J, Sun XL, Wu WZ, Qiu Y, Shu T, Zhao XL, Yin L, Qin CF, Hu YY, Zhou X. Human Enterovirus Nonstructural Protein 2C ATPase Functions as Both an RNA Helicase and ATP-Independent RNA Chaperone. PLoS Pathog. 2015;11:e1005067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4517893</ArticleId><ArticleId IdType="pubmed">26218680</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X, Lei XB, Zhang ZZ, Ma YJ, Qi JL, Wu C, Xiao Y, Li L, He B, Wang JW. Enterovirus 3A facilitates viral replication by promoting PI4&#xa0;KB-ACBD3 interaction. J Virol. 2017;91:e00791-17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5599760</ArticleId><ArticleId IdType="pubmed">28701404</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie SQ, Wang K, Yu WJ, Lu W, Xu K, Wang JW, Ye B, Schwarz WG, Jin Q, Sun B. DIDS blocks a chloride-dependent current that is mediated mediated by the 2B protein of enterovirus 71. Cell Res. 2011;21:1271&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3193483</ArticleId><ArticleId IdType="pubmed">21747413</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu CZ, He X, Zheng ZR, Zhang Z, Wei CW, Guan K, Hou LH, Zhang BC, Zhu L, Cao Y, Zhang YH, Cao Y, Ma SL, Wang PH, Zhang PP, Xu QB, Ling YG, Yang X, Zhong H. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J Virol. 2014;88:11356&#x2013;11368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178780</ArticleId><ArticleId IdType="pubmed">25056901</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LF, He DL, Yang LS, Li ZQ, Ye XZ, Yu H, Zhao H, Li SX, Yuan LZ, Qian HL, Que YQ, Shih JW, Zhu H, Li YM, Cheng T, Xia NS. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loopand VP2 EF Loop of Enterovirus 71. Sci Rep. 2015;5:12973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525384</ArticleId><ArticleId IdType="pubmed">26243660</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CH, Li HC, Jiang JG, Hsu CF, Wang YJ, Lai MJ, Juang YL, Lo SY. Enterovirus type 71 2A protease functions as a transcriptional activator in yeast. J Biomed Sci. 2010;4:17&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2923119</ArticleId><ArticleId IdType="pubmed">20682079</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol. 2011;85:11809&#x2013;11820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang XD, Hu ZL, Fan SS, Zhang Q, Zhong Y, Guo D, Qin YL, Chen MZ. Picornavirus 2A protease regulates stress granule formation to facilitate viral translation. PLoS Pathog. 2018;14:e1006901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5819834</ArticleId><ArticleId IdType="pubmed">29415027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh MT, Wang SW, Yu CK, Lin KH, Lei HY, Su IJ, Wang JR. A Single Nucleotide in Stem Loop II of 59-Untranslated Region Contributes to Virulence of Enterovirus 71 in Mice. PLoS ONE. 2011;6:e27082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3206083</ArticleId><ArticleId IdType="pubmed">22069490</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, He ML. The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol. 2011;37:313&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan SL, Li GM, Wang Y, Gao QQ, Wang YZ, Cui R, Altmeyer R, Zou G. Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles. J Virol. 2015;90:741&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702679</ArticleId><ArticleId IdType="pubmed">26512078</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang FH, Hao CS, Zhang S, Li AQ, Zhang QF, Wu W, Lin L, Li C, Liang MF, Li XL, Li DX. Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge. Virol J. 2014;11:80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022980</ArticleId><ArticleId IdType="pubmed">24885121</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng ZH, Li HX, Zhang ZF, Meng J, Mao D, Bai BK, Lu BJ, Mao PY, Hu QX, Wang HZ. Enterovirus 71 2C protein inhibits TNF-&#x3b1;&#x2013;mediated activation of NF-kB by suppressing Ik&#x3b2; kinase &#x3b2; phosphorylation. J Immunol. 2011;187:2202&#x2013;2212.</Citation><ArticleIdList><ArticleId IdType="pubmed">21810613</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>